White matter injury after repeated endotoxin exposure in the preterm ovine fetus.
Intrauterine infection has been linked to neurologic injury in preterm infants. However, a reproducible model of white matter injury in the preterm fetus in a long gestation species that can be monitored in utero is currently unavailable. Thus, our objective was to determine the effects of bacterial endotoxin (lipopolysaccharide, LPS) on physiologic and inflammatory responses and brain structure in the preterm ovine fetus. At 0.7 of gestation, six catheterized fetuses received three to five intravenous injections of LPS (1 micro g/kg) over 5 d; seven fetuses served as controls. Fetal responses were monitored and brain tissue examined 10-11 d after the initial LPS injection. After LPS on d 1 and 2, fetuses became transiently hypoxemic and hypotensive and blood IL-6 levels were increased, but these responses were smaller or absent after subsequent LPS exposures. Neural injury was observed in all LPS-exposed fetuses, most prominently in the cerebral white matter. Injury ranged from diffuse subcortical damage to periventricular leukomalacia, and in the brainstem the cross-sectional area of the corticospinal tract was reduced by 30%. Thus, repeated exposure of the preterm ovine fetus to LPS causes neuropathology resembling that of cerebral palsy and provides a robust model for exploring the etiology, prevention, and treatment of white matter damage.
Duncan
Jhodie R
JR
Department of Anatomy and Cell Biology, University of Melbourne, Melbourne, Victoria, Australia. J.Duncan@anatomy.unimelb.edu.au
Cock
Megan L
ML
Scheerlinck
Jean-Pierre Y
JP
Westcott
Kerryn T
KT
McLean
Catriona
C
Harding
Richard
R
Rees
Sandra M
SM
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001930:Brain Injuries / Q000209:etiology* / Q000473:pathology; D016207:Cytokines / Q000097:blood; D004195:Disease Models, Animal; D005260:Female; D005312:Fetal Blood / Q000378:metabolism; D005333:Fetus / Q000187:drug effects* / Q000502:physiology; D005865:Gestational Age; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D007249:Inflammation / Q000209:etiology / Q000473:pathology; D007969:Leukomalacia, Periventricular / Q000209:etiology; D008070:Lipopolysaccharides / Q000008:administration & dosage / Q000633:toxicity*; D009836:Oligodendroglia / Q000187:drug effects / Q000473:pathology; D009929:Organ Size / Q000187:drug effects; D011247:Pregnancy; D012756:Sheep
D016207:Cytokines; D008070:Lipopolysaccharides